Animal Models for Post-Tuberculosis Lung Disease: Translational Gaps, Mechanistic Insights, and Future Directions
Journal of Respiration · 2026-11-06 · 6 (4) · 29
DOI: 10.3390/jor6040029 ↗Abstract
Successful tuberculosis (TB) treatment does not necessarily restore pulmonary health, and many TB survivors develop persistent structural and functional lung abnormalities known as post-tuberculosis lung disease (PTLD). Despite its clinical significance, the mechanisms underlying PTLD remain poorly understood, and effective therapies are lacking. Progress is impeded by the absence of preclinical models that adequately reproduce post-treatment features of pulmonary TB. This narrative review evaluates established animal TB models, such as murine, guinea pig, rabbit, and non-human primate models, and their relevance to PTLD research. We assessed their ability to replicate lung pathology, such as fibrosis, cavitation, extracellular matrix remodeling, and persistent inflammation. Additionally, we examined the mechanisms of TB-associated lung injury, including immune dysregulation, matrix metalloproteinase activity, and profibrotic signaling. However, these pathological processes have been studied predominantly during active infection, and their contributions to persistent lung damage following treatment remain insufficiently characterized in existing preclinical models. Major translational gaps include limited emphasis on post-treatment disease, inadequate longitudinal assessment of lung function, and the absence of standardized criteria for defining PTLD in preclinical studies. Finally, we underscore the need for longitudinal animal models incorporating treatment outcomes and clinically relevant endpoints to bridge experimental findings with the persistent pulmonary consequences experienced by TB survivors.
EUVIMED